SCHEMBL4913166

SCHEMBL4913166

CN(C)CCNc1ccnc2ccccc12

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.73
ADRA1D P25100 2/20 0.73
ADRA1A P35348 2/20 0.73
ADRA1B P35368 2/20 0.73
FERMT2 Q96AC1 2/20 0.65
NCF1 P14598 2/20 0.61
GAA P10253 1/20 0.58
ALPG P10696 1/20 0.58
SLC2A1 P11166 1/20 0.58
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
POLB P06746 1/20 0.55
RAD52 P43351 1/20 0.55
SLC40A1 Q9NP59 1/20 0.55
HRH3 Q9Y5N1 3/20 0.55
CYP2C19 P33261 1/20 0.51
ACP1 P24666 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15191325 0.91 HTR1A (0.72) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL15483263 0.91 HTR1A (0.73) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL4142709 0.82 HTR1A (0.80) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL8909254 0.82 HTR1A (0.80) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL30102645 0.82 FERMT2 (0.53) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL15191596 0.81 CYP2C19 (0.49) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL18631820 0.81 HTR1A (0.83) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL18290254 0.80 HTR1A (1.00) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL9850466 0.80 HTR1A (0.89) HTR1AADRA1DADRA1AADRA1BFERMT2
SCHEMBL22390094 0.80 HTR1A (1.00) HTR1AADRA1DADRA1AADRA1BFERMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080045538-A1 Nitro and amino substituted topoisomerase agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2008-02-21 US disclosed
US-6992089-B2 Nitro and amino substituted topoisomerase agents RUTGERS, THE UNIVERSITY OF NEW JERSEY (US) 2006-01-31 US disclosed
US-20040102443-A1 Nitro and amino substituted topoisomerase agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2004-05-27 US disclosed
WO-2004014906-A2 NITRO AND AMINO SUBSTITUTED DIBENZONAPHTHYRIDINES AS TOPOISOMERASE AGENTS RUTGERS, THE STATE UNIVERSITY (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045538-A1 Nitro and amino substituted topoisomerase agents TOP1, TOP2A, TOP2B HTR1A 2567/4885ADRA1D 2545/4885ADRA1A 2182/4885
US-20040102443-A1 Nitro and amino substituted topoisomerase agents TOP1, TOP2A, TOP2B HTR1A 1558/4885ADRA1D 1201/4885ADRA1A 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.